Cancer cells are characterized by chromosome abnormalities, of which some, in particular balanced rearrangements, are associated with distinct tumor entities and/or with specific gene rearrangements that represent important steps in the carcinogenic process. However, the vast majority of cytogenetically detectable structural aberrations in cancer cells have not been characterized at the nucleotide level; hence, their importance and functional consequences are unknown. By ascertaining the chromosomal breakpoints in 22 344 different clonal structural chromosome abnormalities identified in the karyotypes of 49 626 cases of neoplastic disorders we here show that the distribution of breakpoints is strongly associated (P < 0.0001) with gene content within the affected chromosomal bands. This association also remains highly significant
chromosome abnormalities identified in the karyotypes of 49 626 cases of neoplastic disorders we here show that the distribution of breakpoints is strongly associated (P < 0.0001) with gene content within the affected chromosomal bands. This association also remains highly significant in separate analyses of recurrent and nonrecurrent chromosome abnormalities as well as of specific subtypes of cancer (P < 0.0001 for all comparisons). In contrast, the impact of band length was negligible. The breakpoint distribution is thus not stochastic-gene-rich regions are preferentially affected. Several genomic features relating to transcription, replication, and chromatin organization have been found to enhance chromosome breakage frequencies; this indicates that gene-rich regions may be more break-prone. The salient finding in the present study is that a substantial fraction of all structural chromosome abnormalities, not only those specifically associated with certain tumor types, may affect genes that are pathogenetically important. If this interpretation is correct, then the prevailing view that the great majority of cancer chromosome aberrations is cytogenetic noise can be seriously questioned. Irrespective of their mode of origin, there is ample evidence that gene fusions represent early driver mutations. 4, 6 However, it should be emphasized that only a few neoplasms carry molecularly characterized specific chromosome changes. In fact, most human tumors display apparently unique, usually complex, structural, and/or numerical karyotypic changes and many malignant epithelial tumors harbor cytogenetically unrelated clones. 1 This heterogeneity, complexity, and confusing variety of cytogenetic abnormalities in most cancer cases have led to the view that only a few recurrent primary or secondary abnormalities are pathogenetically important, whereas most cytogenetic changes in fact represent unimportant "noise"-they are not the cause but rather the consequence of the neoplastic state, that is, they merely reflect the chromosomal instability that characterizes cancer cells. 
| Parameters ascertained
The All analyses were performed in SAS 9.4 (SAS Institute Inc., Cary, NC) and a P-value lower than 0.05 was considered significant. Table S1 lists Table 1 . Table 2 shows the associations between number of breakpoints in relation to gene content and band length for all aberrations in AML (n = 6234), ALL (n = 3816), ML (n = 6282), MBST (n = 3858), and MET (n = 5361). Separate analyses for all translocations (n = 16 055) and all recurrent translocations (n = 1660) are given in Table 3 ; the remaining major aberration types (additions, deletions, duplications, and inversions) amounted to only 3624 in total and could not be analyzed separately.
| RESULTS
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As seen in Tables 1-3 0.7716 and 0.8060, respectively). Table 4 substantial fraction of structural chromosome abnormalities, not only those specifically associated with certain tumor types, affects genes that may be of importance for the carcinogenic process. Our results thus indicate that many more genes than previously appreciated may be involved in this process and that the prevailing view that the great majority of cancer chromosome aberrations is noise can be seriously questioned. It may very well be, as our results suggest, that the breakpoints of most chromosome abnormalities, be they primary or secondary, play pathogenetically important roles in tumor development.
